All In MedTech

Device Trial Radar · NCT06662279

Hyrax Vs. Invisalign Palatal Expander Clinical Study

Last checked: Nov 19, 2026Latest source record: Dec 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

36

Planned (sponsor's estimate)

Start

Oct 25, 2024

Primary completion

Nov 2025

Study completion Jan 2026

Sponsor

Lead sponsor
Align Technology, Inc.Public (ALGN)
Sponsor type
Industry
First posted
Oct 28, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 6 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.

Conditions

  • Malocclusions
  • Narrow Maxilla
  • Narrow Maxillary Arch
  • Crowding

Interventions

  • Removable Rapid Palatal ExpanderDevice

    Removable palatal expander where expanders are changed to obtain up to .25mm expansion per expander

  • Banded Palatal ExpanderDevice

    Palatal expander cemented into mouth where a screw is turned to obtain .25mm expansion per turn

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. width of palate after expansionTime frame: from enrollment to study completion, approximately 4 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Orange Coast Orthodontics

    Laguna Hills, California · Recruiting

  • Spillers Orthodontics

    Warner Robins, Georgia · Recruiting

  • Innovative Orthodontic Centers

    Naperville, Illinois · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.